Updated Jul 16, 2026
Selhorn Ryan J is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Ryan J. Selhorn is the Chief Financial Officer of Aytu BioPharma, Inc., a specialty pharmaceutical company focused on prescription therapeutics and consumer health products. His role involves overseeing the financial operations of the company, which is known for its treatments for pediatric conditions.
| Role | Chief Financial Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-10-03 | AYTU | AYTU BIOPHARMA, INC | A — Grant or award | 17.5K | $0.00 | |
| 2025-10-03 | AYTU | AYTU BIOPHARMA, INC | A — Grant or award | 16.2K | $0.00 | |
| 2024-11-13 | AYTU | AYTU BIOPHARMA, INC | A — Grant or award | 14.0K | $0.00 |
Ryan J. Selhorn is the Chief Financial Officer of Aytu BioPharma, Inc., a specialty pharmaceutical company focused on prescription therapeutics and consumer health products. His role involves overseeing the financial operations of the company, which is known for its treatments for pediatric conditions.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Selhorn Ryan J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.